Company news

Corbus Pharmaceuticals Holdings, Inc. news in 2023

Corbus Pharmaceuticals Holdings, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU

December 17, 2023

Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 6, 2023

Corbus Pharmaceuticals Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor Inverse Agonist in a Pre-Clinical Model of Obesity Along with Presentations at Obesity Week 2023

October 16, 2023

Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 7, 2023

Corbus Pharmaceuticals Set to Join Russell Microcap® Index

June 25, 2023

Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 8, 2023

Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update

March 6, 2023

Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA

March 5, 2023

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)

February 12, 2023

Decks in 2023